Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor α

被引:143
作者
Wärnmark, A
Treuter, E
Gustafsson, JÅ
Hubbard, RE
Brzozowski, AM
Pike, ACW [1 ]
机构
[1] Univ York, Dept Chem, Struct Biol Lab, York YO10 5DD, N Yorkshire, England
[2] Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden
关键词
D O I
10.1074/jbc.M200764200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The activation function 2/ligand-dependent interaction between nuclear receptors and their coregulators is mediated by a short consensus motif, the so-called nuclear receptor (NR) box. Nuclear receptors exhibit distinct preferences for such motifs depending both on the bound ligand and on the NR box sequence. To better understand the structural basis of motif recognition, we characterized the interaction between estrogen receptor a and the NR box regions of the p160 coactivator TIF2. We have determined the crystal structures of complexes between the ligand-binding domain of estrogen receptor a and 12-mer peptides from the Box 2 and Box 3 regions of TIF2. Surprisingly, the Box 3 module displays an unexpected binding mode that is distinct from the canonical LXXLL interaction observed in other ligand-binding domain/NR box crystal structures. The peptide is shifted along the coactivator binding site in such a way that the interaction motif becomes LXXLL rather than the classical LXXLL. However, analysis of the binding properties of wild type NR box peptides, as well as mutant peptides designed to probe the Box 3 orientation, suggests that the Box 3 peptide primarily adopts the "classical" LXXLL orientation in solution. These results highlight the potential difficulties in interpretation of protein-protein interactions based on co-crystal structures using short peptide motifs.
引用
收藏
页码:21862 / 21868
页数:7
相关论文
共 42 条
[1]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[2]   STIMULATION OF ESTROGEN RECEPTOR-MEDIATED TRANSCRIPTION AND ALTERATION IN THE PHOSPHORYLATION STATE OF THE RAT UTERINE ESTROGEN-RECEPTOR BY ESTROGEN, CYCLIC ADENOSINE-MONOPHOSPHATE, AND INSULIN-LIKE GROWTH FACTOR-I [J].
ARONICA, SM ;
KATZENELLENBOGEN, BS .
MOLECULAR ENDOCRINOLOGY, 1993, 7 (06) :743-752
[3]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[4]   The histone acetylase PCAF is a nuclear receptor coactivator [J].
Blanco, JCG ;
Minucci, S ;
Lu, JM ;
Yang, XJ ;
Walker, KK ;
Chen, HW ;
Evans, RM ;
Nakatani, Y ;
Ozato, K .
GENES & DEVELOPMENT, 1998, 12 (11) :1638-1651
[5]   Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications [J].
Bourguet, W ;
Germain, P ;
Gronemeyer, H .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (10) :381-388
[6]   Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes [J].
Bramlett, KS ;
Wu, YF ;
Burris, TP .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :909-922
[7]   Cooperativity and dimerization of recombinant human estrogen receptor hormone-binding domain [J].
Brandt, ME ;
Vickery, LE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :4843-4849
[8]  
Brunger AT., 1992, XPLOR
[9]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[10]   Ligand-independent activation of steroid receptors: New roles for old players [J].
Cenni, B ;
Picard, D .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (02) :41-46